Figures
Figure 1 Trial profile
Figure 1 legend: *Two infants in the control group were no longer eligible due to receiving phototherapy for jaundice after randomization. The primary outcome was the cumulative incidence of atopic dermatitis at 12 months.
Abbreviations: CW = Consent withdrawn, LTFU = Lost to follow-up
Figure 2 Point prevalence and cumulative incidence of AD at 12 months in the intervention and control groups
Figure 2 legend: The point prevalence of AD was calculated based on the number of infants in each group who met the UK Working Party Diagnostic Criteria for atopic dermatitis at 12 months (intervention: 24/117, control: 52/136), as assessed by the blinded investigator. The cumulative incidence of AD was calculated based on the number of infants diagnosed with AD at any point in the first 12 months (intervention: 24/117, control: 52/136).
Abbreviations: AD = atopic dermatitis
Figure 3 Kaplan-Meier plot of the proportion of in infants in the intervention and control group
without AD during the first 12 months of life
Figure 3 legend: The intervention group maintained AD-free skin for a longer period in the first 12 months than the control group (P = 0.016, log-rank test).
Abbreviations: AD = atopic dermatitis